Tricyclo[3.3.1.1 3,7]decan-1-amine hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

18 API Suppliers, 7 USDMF, 2 CEP/COS, 1 JDMF, 9 NDC API, 15 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

11 Drugs in Development

11 Drugs in Development

INTERMEDIATES

3 Intermediates Suppliers

3 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

69 FDF Dossiers, 48 FDA Orange Book, 2 Europe, 5 Canada, 2 Australia, 1 South Africa, 11 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - EQ 129MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 161MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 193MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 258MG BASE

RELATED EXCIPIENT COMPANIES

3 Rochem International Inc, 18 SPI Pharma, 11 DKSH, 6 Faran Shimi Pharmaceutical, 8 Boai NKY Pharmaceuticals Ltd, 13 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 ACG Worldwide, 5 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 19 BASF, 11 Corel Pharma Chem, 4 DFE Pharma, 1 Finar, 7 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 5 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 18 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 12 Microlex e.U, 3 Novo Excipients, 3 Pharmatrans-Sanaq, 7 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 30 Roquette, 8 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 3 The Dow Chemical Company, 2 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

82 Fillers, Diluents & Binders, 52 Coating Systems & Additives, 40 Direct Compression, 31 Controlled & Modified Release, 30 Disintegrants & Superdisintegrants, 26 Granulation, 25 Film Formers & Plasticizers, 25 Taste Masking, 24 Thickeners and Stabilizers, 19 Co-Processed Excipients, 18 Lubricants & Glidants, 16 Chewable & Orodispersible Aids, 14 Parenteral, 14 Solubilizers, 9 Empty Capsules, 6 API Stability Enhancers, 6 Emulsifying Agents, 6 Topical, 5 Coloring Agents, 4 Vegetarian Capsules, 3 Rheology Modifiers, 1 Soft Gelatin, 1 Surfactant & Foaming Agents

DIGITAL CONTENT

35 NEWS #PharmaBuzz

35 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 6 Finished Drug Prices

MARKET PLACE

12 APIs, 1 Intermediates

PATENTS & EXCLUSIVITIES

144 US Patents, 2 US Exclusivities

REF. STANDARDS & IMPURITIES

1 EDQM, 2 USP, 3 Others

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 209410 / DOSAGE - TABLET, EXTENDED RELEASE;ORAL - EQ 161MG BASE

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
AMANTADINE(UNII: BF4C9Z1J53) (AMANTADINE - UNII:BF4C9Z1J53)	AMANTADINE	161mg \| 258mg \| 129mg \| 193mg

Inactive Ingredients

Ingredient Name	Vertical Pharmaceuticals, LLC
CELLULOSE ACETATE(3J2P07GVB6)
COPOVIDONE K25-31(D9C330MD8B)
D&C YELLOW NO. 10(35SW5USQ3G)
FD&C BLUE NO. 1(H3R47K3TBD)
FD&C BLUE NO. 2(L06K8R7DQK)
FD&C RED NO. 40(WZB9127XOA)
FD&C YELLOW NO. 6(H77VEI93A8)
FERRIC OXIDE RED(1K09F3G675)
FERRIC OXIDE YELLOW(EX438O2MRT)
FERROSOFERRIC OXIDE(XM0M87F357)
HYPROMELLOSES(3NXW29V3WO)
LACTOSE MONOHYDRATE(EWQ57Q8I5X)
MAGNESIUM STEARATE(70097M6I30)
MICROCRYSTALLINE CELLULOSE(OP1R32D61U)
POLYETHYLENE GLYCOL 400(B697894SGQ)
POLYSORBATE 80(6OZP39ZG8H)
PROPYLENE GLYCOL(6DC9Q167V3)
SILICON DIOXIDE(ETJ7Z6XBU4)
SODIUM CHLORIDE(451W47IQ8X)
TITANIUM DIOXIDE(15FIX9V2JP)
TRIACETIN(XHX3C3X673)

Drug Product Composition: Tricyclo[3.3.1.1 3,7]decan-1-amine hydrochloride